MX9710389A - Antagonistas del receptor de vitronectina, su preparacion y empleo del mismo. - Google Patents
Antagonistas del receptor de vitronectina, su preparacion y empleo del mismo.Info
- Publication number
- MX9710389A MX9710389A MX9710389A MX9710389A MX9710389A MX 9710389 A MX9710389 A MX 9710389A MX 9710389 A MX9710389 A MX 9710389A MX 9710389 A MX9710389 A MX 9710389A MX 9710389 A MX9710389 A MX 9710389A
- Authority
- MX
- Mexico
- Prior art keywords
- antagonists
- preparation
- vitronectine
- receiver
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Los antagonistas del receptor de vitronectina, cuya preparacion y empleo son objeto de la presente invencion, son compuestos de formula I A-B-D-E-F-G en la que A, B, D, E, F Y G tienen los significados que se indican en las reivindicaciones de la patente, su preparacion y su empleo como medicamento. Los compuestos segun la invencion se emplean como antagonistas del receptor de vitronectina y como inhibidores de la absorcion osea.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19653645A DE19653645A1 (de) | 1996-12-20 | 1996-12-20 | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
DE19653645.6 | 1996-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9710389A true MX9710389A (es) | 1998-08-30 |
MXPA97010389A MXPA97010389A (es) | 1998-11-12 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
JPH10182617A (ja) | 1998-07-07 |
NO975975L (no) | 1998-06-22 |
ID19245A (id) | 1998-06-28 |
CA2225267A1 (en) | 1998-06-20 |
AR010369A1 (es) | 2000-06-07 |
TR199701645A3 (tr) | 1998-07-21 |
ZA9711315B (en) | 1998-06-22 |
EP0854145A3 (de) | 2000-03-22 |
KR19980064419A (ko) | 1998-10-07 |
EP0854145A2 (de) | 1998-07-22 |
IL122643A0 (en) | 1998-08-16 |
NO975975D0 (no) | 1997-12-19 |
TR199701645A2 (xx) | 1998-07-21 |
PL323968A1 (en) | 1998-06-22 |
CN1200373A (zh) | 1998-12-02 |
DE19653645A1 (de) | 1998-06-25 |
AU729760B2 (en) | 2001-02-08 |
HU9702509D0 (en) | 1998-03-02 |
HUP9702509A3 (en) | 2001-04-28 |
HUP9702509A2 (hu) | 1999-06-28 |
NZ329429A (en) | 1999-05-28 |
AU4846497A (en) | 1998-06-25 |
CZ411297A3 (cs) | 1998-07-15 |
BR9706386A (pt) | 2003-04-22 |
US5990145A (en) | 1999-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9710392A (es) | Antagonistas de receptores de vitronectina, su preparacion asi como su empleo. | |
IL125223A0 (en) | Novel substituted imidazole compounds | |
HK1022624A1 (en) | Novel substituted imidazole compounds. | |
MX9700885A (es) | Nuevas heteroariloxazolidinonas. | |
YU28199A (sh) | Novi oblik jedinjenja | |
HUP0200355A2 (en) | 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use | |
MX9700557A (es) | Dihidrobenzofuranos. | |
ES2136037A1 (es) | Inhibidores de sulfamida-metaloproteasa | |
YU22000A (sh) | Biciklični inhibitori kinaze | |
MX9702070A (es) | Nuevos inhibidores de resorcion osea y antagonistas de receptor de vitronectina. | |
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
BG101110A (en) | Substituted pyrimidine compounds and their application | |
MX9709240A (es) | Fenilpiridazinonas. | |
SE9704546D0 (sv) | Novel compounds | |
YU19499A (sh) | Benzonaftiridini kao bronhijalni terapeutici | |
BG103096A (en) | Thrombin inhibitors | |
BG99177A (en) | New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
MX9801987A (es) | Nuevos derivados de aminoacido, su obtencion y su uso. | |
SE9802937D0 (sv) | Novel compounds | |
EP0635263A3 (en) | Angiotensin II antagonists (AII) as inhibitors of the growth of adipose tissue. | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
MX9710389A (es) | Antagonistas del receptor de vitronectina, su preparacion y empleo del mismo. | |
EP0778833A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
AP9200443A0 (en) | Heterocyclic compounds. |